Skip to content

Vera Therapeutics, Inc.

VERA

CIK 0001831828

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$329.55M
−96.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.96
−69.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$221.24M
Q1 May 2026
Cash
$114.35M
Q1 May 2026
Total Debt
$75.03M
Q1 May 2026
Shares Outstanding
71.78M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings